The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...

The National Pharmaceutical Pricing Authority (NPPA) has notified the retail price of 53 new drugs based on applications submitted by individual companies, after finalising the same in the latest ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited ... manufacture of sofosbuvir and the investigational single tablet regimen of ledipasvir/sofosbuvir for distribution ...

Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market due to manufacturing issues, according to the ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture ...

Sun Pharma and Zydus Pharmaceuticals are recalling significant quantities of their products in the US due to manufacturing ...

Revealing that the company initiated the Class-II nationwide (US) recall on February 6, 2025, the USFDA reported that Zydus ...

Zydus Lifesciences shares surged 7% to an intraday high of Rs 947.95 on the BSE on Thursday after receiving final approval ...

Zydus Lifesciences Ltd on Wednesday (March 5) said it has received final approval from the United States Food and Drug ...

Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets, strengthening position in US market.